Healthcare Realty Trust (NYSE:HR) Reaches New 52-Week High – Still a Buy?

Shares of Healthcare Realty Trust Incorporated (NYSE:HRGet Free Report) reached a new 52-week high on Wednesday . The company traded as high as $20.59 and last traded at $20.5150, with a volume of 1812814 shares. The stock had previously closed at $20.20.

Analyst Ratings Changes

HR has been the subject of several recent research reports. Scotiabank upped their price target on Healthcare Realty Trust from $20.00 to $22.00 and gave the company an “outperform” rating in a report on Friday, May 8th. Cantor Fitzgerald lifted their price objective on Healthcare Realty Trust from $21.00 to $22.00 and gave the stock an “overweight” rating in a report on Monday, May 4th. UBS Group upped their target price on Healthcare Realty Trust from $18.00 to $20.00 and gave the company a “buy” rating in a research note on Wednesday, May 13th. Citigroup raised their target price on Healthcare Realty Trust from $19.00 to $21.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Finally, Wall Street Zen upgraded shares of Healthcare Realty Trust from a “sell” rating to a “hold” rating in a research note on Saturday, January 31st. Four equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, Healthcare Realty Trust has an average rating of “Hold” and an average price target of $20.25.

Get Our Latest Stock Analysis on Healthcare Realty Trust

Healthcare Realty Trust Stock Up 1.2%

The stock has a market cap of $7.08 billion, a price-to-earnings ratio of -35.26 and a beta of 0.97. The company’s 50-day moving average is $18.38 and its 200-day moving average is $17.83.

Healthcare Realty Trust (NYSE:HRGet Free Report) last released its quarterly earnings data on Thursday, April 30th. The real estate investment trust reported $0.41 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.02. Healthcare Realty Trust had a negative return on equity of 4.29% and a negative net margin of 17.34%.The company had revenue of $275.28 million for the quarter, compared to the consensus estimate of $283.01 million. During the same period in the previous year, the business earned $0.39 earnings per share. The company’s quarterly revenue was down 7.7% on a year-over-year basis. Healthcare Realty Trust has set its FY 2026 guidance at 1.590-1.65 EPS. On average, research analysts forecast that Healthcare Realty Trust Incorporated will post 1.61 earnings per share for the current year.

Healthcare Realty Trust Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 22nd. Shareholders of record on Monday, May 11th will be given a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a yield of 4.7%. The ex-dividend date is Monday, May 11th. Healthcare Realty Trust’s dividend payout ratio is -165.52%.

Insider Transactions at Healthcare Realty Trust

In related news, Director Thomas N. Bohjalian acquired 10,000 shares of the business’s stock in a transaction on Friday, March 6th. The stock was bought at an average cost of $18.09 per share, with a total value of $180,900.00. Following the completion of the acquisition, the director owned 85,520 shares in the company, valued at $1,547,056.80. The trade was a 13.24% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.56% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Healthcare Realty Trust

Hedge funds have recently made changes to their positions in the company. PGGM Investments bought a new position in Healthcare Realty Trust during the 4th quarter valued at about $113,389,000. Resolution Capital Ltd grew its stake in Healthcare Realty Trust by 72.4% during the first quarter. Resolution Capital Ltd now owns 14,034,367 shares of the real estate investment trust’s stock worth $238,444,000 after buying an additional 5,892,501 shares during the last quarter. Invesco Ltd. increased its holdings in shares of Healthcare Realty Trust by 233.8% during the third quarter. Invesco Ltd. now owns 7,700,760 shares of the real estate investment trust’s stock worth $138,845,000 after buying an additional 5,393,651 shares in the last quarter. Norges Bank bought a new position in shares of Healthcare Realty Trust in the fourth quarter valued at approximately $62,154,000. Finally, Jupiter Asset Management Ltd. bought a new position in shares of Healthcare Realty Trust in the fourth quarter valued at approximately $31,810,000.

About Healthcare Realty Trust

(Get Free Report)

Healthcare Realty Trust (NYSE: HR) is a real estate investment trust specializing in the ownership, acquisition and management of outpatient medical facilities. Headquartered in Nashville, Tennessee, the company’s portfolio is focused primarily on medical office buildings and outpatient healthcare properties that serve hospitals, health systems and other healthcare providers. Its business model centers on securing long-term, triple-net leases to generate stable income streams from a diversified tenant base.

The company’s properties are located across key metropolitan markets in the United States, including major healthcare hubs in the Southeast, Southwest and in select coastal regions.

Read More

Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.